Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy. IHJPAS. 2018;31(3):63-69. doi:10.30526/31.3.2011